Search research articles
Contact Us
Filters
Showing results (61-70 of 106) with videos related to
Page
of 11
Sort By:
Cancers
|
December 18, 2020
Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures
Sofia Karkampouna, Maria R De Filippo, Charlotte K Y Ng, et al.
Translational Andrology and Urology
|
October 11, 2022
Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohort
Giancarlo Marra, Marco Oderda, Giorgio Calleris, et al.
European Urology
|
June 29, 2010
Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients
David Brix, Bruno Allolio, Wiebke Fenske, et al.
Cancer Research
|
March 11, 2014
Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3
Burkhard Kneitz, Markus Krebs, Charis Kalogirou, et al.
Plos One
|
June 19, 2015
DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer
Kirill Litovkin, Aleyde Van Eynde, Steven Joniau, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 22, 2023
ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer
Nina-Sophie Schmidt-Hegemann, Constantinos Zamboglou, Malcolm Mason, et al.
Endocrine Connections
|
June 20, 2013
Relaxed imprinting of IGF2 in peripheral blood cells of patients with a history of prostate cancer
Djeda Belharazem, Matthias Kirchner, Franziska Geissler, et al.
European Urology
|
March 20, 2010
Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients
Martin Spahn, Steven Joniau, Paolo Gontero, et al.
BMC Cancer
|
June 27, 2019
miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo
Mirjam Kiener, Lanpeng Chen, Markus Krebs, et al.
BJU International
|
March 12, 2011
Is there a prostate-specific antigen upper limit for radical prostatectomy?
Paulo Gontero, Martin Spahn, Bertrand Tombal, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 106) with videos related to
Sort By:
Page
of 11
Cancers
|
December 18, 2020
Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures
Sofia Karkampouna, Maria R De Filippo, Charlotte K Y Ng, et al.
Translational Andrology and Urology
|
October 11, 2022
Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohort
Giancarlo Marra, Marco Oderda, Giorgio Calleris, et al.
European Urology
|
June 29, 2010
Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients
David Brix, Bruno Allolio, Wiebke Fenske, et al.
Cancer Research
|
March 11, 2014
Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3
Burkhard Kneitz, Markus Krebs, Charis Kalogirou, et al.
Plos One
|
June 19, 2015
DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer
Kirill Litovkin, Aleyde Van Eynde, Steven Joniau, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 22, 2023
ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer
Nina-Sophie Schmidt-Hegemann, Constantinos Zamboglou, Malcolm Mason, et al.
Endocrine Connections
|
June 20, 2013
Relaxed imprinting of IGF2 in peripheral blood cells of patients with a history of prostate cancer
Djeda Belharazem, Matthias Kirchner, Franziska Geissler, et al.
European Urology
|
March 20, 2010
Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients
Martin Spahn, Steven Joniau, Paolo Gontero, et al.
BMC Cancer
|
June 27, 2019
miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo
Mirjam Kiener, Lanpeng Chen, Markus Krebs, et al.
BJU International
|
March 12, 2011
Is there a prostate-specific antigen upper limit for radical prostatectomy?
Paulo Gontero, Martin Spahn, Bertrand Tombal, et al.
Page
of 11